Yosuke Moteki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yosuke Moteki has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Yoshikazu Okada
Department of Neurosurgery, St. Luke's International Hospital, Tokyo, Japan
10 shared publicationsYasunari Niimi
Department of Neuroendovascular therapy, St. Luke's International Hospital, Tokyo, Japan
7 shared publicationsTatsuya Inoue
Department of Neurosurgery, St. Luke's International Hospital, Tokyo, Japan
5 shared publicationsShogo Shima
Department of Neurosurgery, St. Luke's International Hospital, Tokyo, Japan
4 shared publicationsTakakazu Kawamata
Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan
4 shared publicationsTomonori Kobayashi
Department of Neurosurgery, Ebina General Hospital, Kanagawa, Japan
4 shared publications
Latest Publications
- 26 November 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 248, 108645
Long-term results and neuropathy of internal carotid artery aneurysms treated with high-flow bypass using saphenous vein graft and parent artery occlusion
- 26 November 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 248, 108645
Long-term results and neuropathy of internal carotid artery aneurysms treated with high-flow bypass using saphenous vein graft and parent artery occlusion
- 26 March 2021
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 50 (4) , 405-411
Clinical Significance of Cytotoxic Lesions of the Corpus Callosum in Subarachnoid Hemorrhage Patients: A Retrospective Analysis
Introduction: Cytotoxic lesions of the corpus callosum are secondary lesions induced by significant increases in cytokine levels in the brain and are associated with subarachnoid hemorrhage (SAH). However, their clinical significance in SAH patients remains unclear. Methods: We retrospectively analyzed SAH patients who were treated in our hospital and evaluated between-group differences in the backgrounds, clinical findings, and outcomes between SAH patients who developed cytotoxic lesions of the corpus callosum and those who did not. We further compared patients who achieved good outcomes with those who had poor outcomes. Multivariate logistic regression analysis was used to identify risk factors for poor clinical outcomes. Results: We analyzed 159 SAH patients; 17 patients (10.7%) had cytotoxic lesions of the corpus callosum. Patients with cytotoxic lesions of the corpus callosum were more likely to be in a severe condition (World Federation of Neurosurgical Societies grading IV-V: odds ratio [OR], 4.53; 95% confidence interval [95% CI]: 1.60–12.84; p = 0.0042) and have an intraventricular (OR, 5.98; 95% CI: 1.32–27.13; p = 0.0054) or an intraparenchymal hematoma (OR, 3.62; 95% CI: 1.25–10.45; p = 0.023). Patients with cytotoxic lesions of the corpus callosum had a greater propensity of a poor outcome 3 months after onset (modified Rankin Scale score 0–2: OR, 0.22; 95% CI: 0.07–0.66; p = 0.0043). Multivariate analysis confirmed that cytotoxic lesions of the corpus callosum increased the risk of a poor outcome (OR, 4.39; 95% CI: 1.06–18.1; p = 0.037). Discussion/Conclusions: The development of cytotoxic lesions of the corpus callosum may be related to the extent of hematomas in SAH patients. Although they are usually reversible lesions, the development of cytotoxic lesions of the corpus callosum may be a predictor of poor outcomes in SAH patients.
- 26 March 2021
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 50 (4) , 405-411
Clinical Significance of Cytotoxic Lesions of the Corpus Callosum in Subarachnoid Hemorrhage Patients: A Retrospective Analysis
Introduction: Cytotoxic lesions of the corpus callosum are secondary lesions induced by significant increases in cytokine levels in the brain and are associated with subarachnoid hemorrhage (SAH). However, their clinical significance in SAH patients remains unclear. Methods: We retrospectively analyzed SAH patients who were treated in our hospital and evaluated between-group differences in the backgrounds, clinical findings, and outcomes between SAH patients who developed cytotoxic lesions of the corpus callosum and those who did not. We further compared patients who achieved good outcomes with those who had poor outcomes. Multivariate logistic regression analysis was used to identify risk factors for poor clinical outcomes. Results: We analyzed 159 SAH patients; 17 patients (10.7%) had cytotoxic lesions of the corpus callosum. Patients with cytotoxic lesions of the corpus callosum were more likely to be in a severe condition (World Federation of Neurosurgical Societies grading IV-V: odds ratio [OR], 4.53; 95% confidence interval [95% CI]: 1.60–12.84; p = 0.0042) and have an intraventricular (OR, 5.98; 95% CI: 1.32–27.13; p = 0.0054) or an intraparenchymal hematoma (OR, 3.62; 95% CI: 1.25–10.45; p = 0.023). Patients with cytotoxic lesions of the corpus callosum had a greater propensity of a poor outcome 3 months after onset (modified Rankin Scale score 0–2: OR, 0.22; 95% CI: 0.07–0.66; p = 0.0043). Multivariate analysis confirmed that cytotoxic lesions of the corpus callosum increased the risk of a poor outcome (OR, 4.39; 95% CI: 1.06–18.1; p = 0.037). Discussion/Conclusions: The development of cytotoxic lesions of the corpus callosum may be related to the extent of hematomas in SAH patients. Although they are usually reversible lesions, the development of cytotoxic lesions of the corpus callosum may be a predictor of poor outcomes in SAH patients.
- Open Access
- 1 December 2020
- Published by Elsevier in Interdisciplinary Neurosurgery
- Vol. 22
Mild angioplasty with a stent retriever for acute atherothrombotic middle cerebral artery occlusion: A case report
- 1 December 2020
- Published by Elsevier in Interdisciplinary Neurosurgery
- Vol. 22
Open AccessMild angioplasty with a stent retriever for acute atherothrombotic middle cerebral artery occlusion: A case report
- 5 October 2020
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 49 (5) , 531-539
Prognostic Significance of Hyponatremia in Acute Stroke: A Systematic Review and Meta-Analysis
Objective: Hyponatremia is a common electrolyte disorder in patients with stroke, which leads to various fatal complications. We performed a systematic review and meta-analysis to investigate the outcomes of acute stroke patients with hyponatremia. Methods: We searched MEDLINE, EMBASE, and the Cochrane Library databases for relevant literature in English published up to March 2020. Two review authors independently screened and selected the studies by assessing the eligibility and validity based on the inclusion criteria. Mortality at 90 days was set as the primary end point, and in-hospital mortality and length of hospital stay were set as the secondary end points. We conducted the data synthesis and analyzed the outcomes by calculating the odds ratio (OR) and mean difference. Results: Of 835 studies, 15 studies met the inclusion criteria (n = 10,745). The prevalence rate of stroke patients with hyponatremia was 7.0–59.2%. They had significantly higher 90-day mortality (OR, 1.73; 95% confidence interval (CI), 1.24–2.42) and longer length of hospital stay (mean difference, 10.68 days; 95% CI, 7.14–14.22) than patients without hyponatremia. Patients with hyponatremia had a higher tendency of in-hospital mortality than those without hyponatremia (OR, 1.61; 95% CI, 0.97–2.69). Conclusions: The development of hyponatremia in the clinical course of stroke is associated with higher short-term mortality and a longer hospital stay. Although the causal relationship is unclear, hyponatremia could be a significant predictor of poor outcomes after stroke.
- 5 October 2020
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 49 (5) , 531-539
Prognostic Significance of Hyponatremia in Acute Stroke: A Systematic Review and Meta-Analysis
Objective: Hyponatremia is a common electrolyte disorder in patients with stroke, which leads to various fatal complications. We performed a systematic review and meta-analysis to investigate the outcomes of acute stroke patients with hyponatremia. Methods: We searched MEDLINE, EMBASE, and the Cochrane Library databases for relevant literature in English published up to March 2020. Two review authors independently screened and selected the studies by assessing the eligibility and validity based on the inclusion criteria. Mortality at 90 days was set as the primary end point, and in-hospital mortality and length of hospital stay were set as the secondary end points. We conducted the data synthesis and analyzed the outcomes by calculating the odds ratio (OR) and mean difference. Results: Of 835 studies, 15 studies met the inclusion criteria (n = 10,745). The prevalence rate of stroke patients with hyponatremia was 7.0–59.2%. They had significantly higher 90-day mortality (OR, 1.73; 95% confidence interval (CI), 1.24–2.42) and longer length of hospital stay (mean difference, 10.68 days; 95% CI, 7.14–14.22) than patients without hyponatremia. Patients with hyponatremia had a higher tendency of in-hospital mortality than those without hyponatremia (OR, 1.61; 95% CI, 0.97–2.69). Conclusions: The development of hyponatremia in the clinical course of stroke is associated with higher short-term mortality and a longer hospital stay. Although the causal relationship is unclear, hyponatremia could be a significant predictor of poor outcomes after stroke.
- 1 February 2020
- Published by Elsevier in World Neurosurgery
- Vol. 134, 668
In Reply to the Letter to the Editor Regarding “Langerhans Cell Histiocytosis of the Skull in the Burr Hole Site Covered with Hydroxyapatite Material”
- 1 February 2020
- Published by Elsevier in World Neurosurgery
- Vol. 134, 668
In Reply to the Letter to the Editor Regarding “Langerhans Cell Histiocytosis of the Skull in the Burr Hole Site Covered with Hydroxyapatite Material”
- 1 October 2019
- Published by Elsevier in Brain and Development
- Vol. 41 (9) , 812-816
Novel RASA1 mutations in Japanese pedigrees with capillary malformation-arteriovenous malformation
- 1 October 2019
- Published by Elsevier in Brain and Development
- Vol. 41 (9) , 812-816
Novel RASA1 mutations in Japanese pedigrees with capillary malformation-arteriovenous malformation
- 4 April 2019
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 47 (3-4) , 105-111
Genotype-Phenotype Correlation in Long-Term Cohort of Japanese Patients with Moyamoya Disease
Background: Homozygosity of this p.R4810K founder variant of RNF213 moyamoya disease (MMD) susceptibility gene is known to influence the severity of the clinical disease phenotype at disease onset. However, the association between this genotype and long-term clinical manifestations has remained unclear. Objectives: The principal goal of this study was to investigate whether and how the p.R4810K variant of RNF213 influences the long-term phenotype in Japanese patients with MMD. Method: This retrospective cohort study included 94 Japanese patients with MMD who underwent direct or combined bypass for revascularization with the p.R4810K genotype determined in our hospital. The following phenotypic parameters were analyzed at disease onset and over a long-term period: age and initial presentation at onset, recurrent stroke after initial revascularization, and final modified Rankin Scale. Results: The p.R4810K genotype was significantly associated with the phenotype at onset, especially in younger patients. Over a median follow-up period of 100 months, recurrent stroke occurred in 6 out of 94 patients: none out of 5 patients with the homozygous variant, 5 out of 64 with the heterozygous variant, and 1 out of 25 in the wild-type group. There were no significant differences among the genotypes. In particular, recurrent cerebral hemorrhage occurred in 5 patients, all possessing the heterozygous variant. The log-rank test showed no difference between the genotypes in the stroke-free survival rate. Furthermore, the p.R4810K genotype was not associated with a poor functional condition. Conclusions: The p.R4810K founder variant of RNF213 affects the phenotype at disease onset. However, the optimal revascularization may be effective, regardless of the genotype, even for the homozygous variant, which has been thought to be the most pathogenic. This genotype may not strongly influence the long-term clinical manifestations or poor prognosis in MMD.
- 4 April 2019
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 47 (3-4) , 105-111
Genotype-Phenotype Correlation in Long-Term Cohort of Japanese Patients with Moyamoya Disease
Background: Homozygosity of this p.R4810K founder variant of RNF213 moyamoya disease (MMD) susceptibility gene is known to influence the severity of the clinical disease phenotype at disease onset. However, the association between this genotype and long-term clinical manifestations has remained unclear. Objectives: The principal goal of this study was to investigate whether and how the p.R4810K variant of RNF213 influences the long-term phenotype in Japanese patients with MMD. Method: This retrospective cohort study included 94 Japanese patients with MMD who underwent direct or combined bypass for revascularization with the p.R4810K genotype determined in our hospital. The following phenotypic parameters were analyzed at disease onset and over a long-term period: age and initial presentation at onset, recurrent stroke after initial revascularization, and final modified Rankin Scale. Results: The p.R4810K genotype was significantly associated with the phenotype at onset, especially in younger patients. Over a median follow-up period of 100 months, recurrent stroke occurred in 6 out of 94 patients: none out of 5 patients with the homozygous variant, 5 out of 64 with the heterozygous variant, and 1 out of 25 in the wild-type group. There were no significant differences among the genotypes. In particular, recurrent cerebral hemorrhage occurred in 5 patients, all possessing the heterozygous variant. The log-rank test showed no difference between the genotypes in the stroke-free survival rate. Furthermore, the p.R4810K genotype was not associated with a poor functional condition. Conclusions: The p.R4810K founder variant of RNF213 affects the phenotype at disease onset. However, the optimal revascularization may be effective, regardless of the genotype, even for the homozygous variant, which has been thought to be the most pathogenic. This genotype may not strongly influence the long-term clinical manifestations or poor prognosis in MMD.
- 1 February 2019
- Published by Elsevier in World Neurosurgery
- Vol. 122, 632-637
Langerhans Cell Histiocytosis of the Skull in a Burr Hole Site Covered with Hydroxyapatite Material
- 1 February 2019
- Published by Elsevier in World Neurosurgery
- Vol. 122, 632-637
Langerhans Cell Histiocytosis of the Skull in a Burr Hole Site Covered with Hydroxyapatite Material
- 1 August 2018
- Published by Elsevier in World Neurosurgery
- Vol. 116, e505-e512
Ruptured Vertebral Artery Dissecting Aneurysm as a Risk Factor for Ocular Symptoms Accompanied with Subarachnoid Hemorrhage
- 1 August 2018
- Published by Elsevier in World Neurosurgery
- Vol. 116, e505-e512
Ruptured Vertebral Artery Dissecting Aneurysm as a Risk Factor for Ocular Symptoms Accompanied with Subarachnoid Hemorrhage
- 1 January 2018
- Published by Elsevier in World Neurosurgery
- Vol. 109, 110-114
The Availability of a Tin-Alloyed Omnidirectional Retractor-Supporting Ring for Ventriculoperitoneal Shunt Laparotomy
- 1 January 2018
- Published by Elsevier in World Neurosurgery
- Vol. 109, 110-114
The Availability of a Tin-Alloyed Omnidirectional Retractor-Supporting Ring for Ventriculoperitoneal Shunt Laparotomy